Category: Press Release

bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US market
Post

bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US market

Knokke-Heist (Belgium), 9 December 2024, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, is a Euronext Paris listed company and specializes in the development, production, and marketing of oral, denture, orthodontic, and wound care products. As a leader in dental care innovation, bonyf is committed to advancing oral health solutions that enhance patient well-being. Today, the company is pleased to announce a significant milestone: the successful certification of NitrAdine® Disinfecting Tablets under the stringent European Union’s Medical Device Regulation (MDR), marking a new chapter in its pursuit of excellence.

bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions
Post

bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions

Knokke-Heist (Belgium), 9 December 2024, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, is a Euronext Paris listed company and specializes in the development, production, and marketing of oral, denture, orthodontic, and wound care products. As a leader in dental care innovation, bonyf is committed to advancing oral health solutions that enhance patient well-being. Today, the company is pleased to announce a significant milestone: the successful certification of NitrAdine® Disinfecting Tablets under the stringent European Union’s Medical Device Regulation (MDR), marking a new chapter in its pursuit of excellence.

bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India
Post

bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India

Knokke-Heist (Belgium), 28 November 2024, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, is a Euronext Paris listed company and specializes in the development, production, and marketing of oral, denture, orthodontic, and wound care products. bonyf NV and Group pharmaceuticals Ltd are pleased to announce a strategic alliance with a license agreement on the NitrAdine® formulation to manufacture and distribute in India the bonyf products NitrAdine® denture cleansing & disinfecting tablets.

PerioTabs®: Innovative 10-Day NitrAdine®-Based Treatment to Revolutionize Oral Care
Post

PerioTabs®: Innovative 10-Day NitrAdine®-Based Treatment to Revolutionize Oral Care

Ghent (Belgium), 24 October 2024, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, is a Euronext Paris listed company and specializes in the development, production and marketing of oral, denture, orthodontic and wound care products and a leader in dental care innovation. PerioTabs® is proud to introduce its groundbreaking 10-day treatment brushing solution based on the NitrAdine® formula.

Annual Results 2023
Post

Annual Results 2023

Ghent (Belgium), 2 September 2024, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, is a Euronext Paris listed company and specializes in the development, production and marketing of oral, denture, orthodontic and wound care products and a leader in dental care innovation. bonyf R&D team is excited to introduce a scientifically advanced formulation designed to provide rapid relief from the discomfort associated with heel and finger cracks.

bonyf’s Advanced Skincare Formula Offers Fast Relief for Heel and Finger Cracks
Post

bonyf’s Advanced Skincare Formula Offers Fast Relief for Heel and Finger Cracks

Ghent (Belgium), 2 September 2024, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, is a Euronext Paris listed company and specializes in the development, production and marketing of oral, denture, orthodontic and wound care products and a leader in dental care innovation. bonyf R&D team is excited to introduce a scientifically advanced formulation designed to provide rapid relief from the discomfort associated with heel and finger cracks.

NitrAdine® Dental Effervescent Tabs: Revolutionizing dental hygiene with unrivalled disinfecting power
Post

NitrAdine® Dental Effervescent Tabs: Revolutionizing dental hygiene with unrivalled disinfecting power

Ghent (Belgium), 9 August 2024, 6:00 p.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, is a Euronext Paris listed company and specializes in the development, production and marketing of oral, denture, orthodontic and wound care products and a leader in dental care innovation, is proud to highlight the exceptional efficacy of NitrAdine®, a leading product in the field of dental hygiene. Classified as a Class IIb medical device, NitrAdine® complies with the rigorous European Standards ensuring the highest level of safety and efficacy.

Olivafix® Gold: Showcasing Our Pioneering R&D in Denture Adhesives
Post

Olivafix® Gold: Showcasing Our Pioneering R&D in Denture Adhesives

Ghent (Belgium), 7 June 2024, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, is a Euronext Paris listed company and specializes in the development, production and marketing of oral, denture, orthodontic and wound care products, is proud to reaffirm our commitment to R&D, as well as to highlight the proven effectiveness of our unique fast pain-relief mouth ulcer cream AphtoFix®.

bonyf NV: bonyf’s 2023 financial statements made available
Post

bonyf NV: bonyf’s 2023 financial statements made available

Ghent (Belgium), 7 June 2024, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, is a Euronext Paris listed company and specializes in the development, production and marketing of oral, denture, orthodontic and wound care products, is proud to reaffirm our commitment to R&D, as well as to highlight the proven effectiveness of our unique fast pain-relief mouth ulcer cream AphtoFix®.

Advanced R&D capabilities and proven efficacy of our unique fast pain-relief mouth ulcer cream
Post

Advanced R&D capabilities and proven efficacy of our unique fast pain-relief mouth ulcer cream

Ghent (Belgium), 7 June 2024, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, is a Euronext Paris listed company and specializes in the development, production and marketing of oral, denture, orthodontic and wound care products, is proud to reaffirm our commitment to R&D, as well as to highlight the proven effectiveness of our unique fast pain-relief mouth ulcer cream AphtoFix®.